Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
287 participants
OBSERVATIONAL
2011-01-31
2011-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Primary outcome: an examination of demographic data, predicted mortality rates and the clinical diagnosis of the patients Secondary outcome: to determine the terminal cancer ratio Inclusion criteria: patients throughout the hole hospital whom was intubated by the anaesthesiology team due to an emergency consultation call Exclusion criteria: patients who refused treatment
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Incidence of Perioperative Hypothermia in Patients With Elective Surgery Under General Anesthesia in Turkey
NCT02736630
End Tidal Anesthetic Concentration in Different Anesthesia Techniques Where Depth of Anesthesia Adjusted With Entropy
NCT04203290
National Epidemiologic Survey on the Incidence of Perioperative Hypothermia
NCT02211703
Evaluation of The Relationship Between Perioperative Hypothermia and Emergence Agitation
NCT06543134
Pilot Implementation of the Postoperative Hypothermia Management Care Bundle
NCT06829017
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Predicted mortality values were calculated for each patient with Apache II and SAPS II values using the worst or most critical physiological and laboratory parameters in the first 24 hours in the Emergency Department.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gulsah Karaoren
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gulsah Karaoren
Doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Huseyin Oz, Prof Dr
Role: STUDY_DIRECTOR
Medipol University Faculty of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Istanbul University Faculty of Cerrahpasa Medicine
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Kim AS, Youn CH, Ko HJ, Kim HM. The survival time of terminal cancer patients: prediction based on clinical parameters and simple prognostic scores. J Palliat Care. 2014 Spring;30(1):24-31.
Uy J, White DB, Mohan D, Arnold RM, Barnato AE. Physicians' decision-making roles for an acutely unstable critically and terminally ill patient. Crit Care Med. 2013 Jun;41(6):1511-7. doi: 10.1097/CCM.0b013e318287f0dd.
Lissauer ME, Naranjo LS, Kirchoffner J, Scalea TM, Johnson SB. Patient characteristics associated with end-of-life decision making in critically ill surgical patients. J Am Coll Surg. 2011 Dec;213(6):766-70. doi: 10.1016/j.jamcollsurg.2011.09.003.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GK2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.